05th week of 2009 patent applcation highlights part 50 |
Patent application number | Title | Published |
20090030019 | PURINE DERIVATIVES HAVING, IN PARTICULAR, ANTI-PROLIFERATIVE PROPERTIES, AND THEIR BIOLOGICAL USES - This invention provides 2-, 6, and 9-substituted purine derivatives, particularly 2(1-R hydroxymethylpropylamino)-6-benzylamino-9-isopropyl purine, having, in particular, antiproliferative properties, and suitable for use as pharmaceutical compositions and herbicidal compositions. Also provided are pharmaceutical compositions and herbicidal compositions comprising the 2-, 6, and 9-substituted purine derivatives, and methods of treatment using the 2-, 6, and 9-substituted purine derivatives. | 2009-01-29 |
20090030020 | 7H-Pyrido[3,4-D]Pyrimidin-8-Ones, Their Manufacture and Use as Protein Kinase Inhibitors - Objects of the present invention are the compounds of formula I | 2009-01-29 |
20090030021 | Quinazoline Derivatives and Therapeutic Use Thereof - Quinazoline derivatives represented by the general formula | 2009-01-29 |
20090030022 | Fungicidal Composition Comprising Cyprodinil - A fungicidal composition in the form of a liquid concentrate, which, in addition to at least one formulation adjuvant, comprises cyprodinil and an unsaturated C | 2009-01-29 |
20090030023 | PYRIMIDINE COMPOUNDS AND MEDICINAL COMPOSITION THEREOF - A compound represented by the following formula (I), a salt, or a solvate thereof: | 2009-01-29 |
20090030024 | THIAZOLES AS FUNGICIDES - Use of compounds of the formula (I), | 2009-01-29 |
20090030025 | TRANS-FUSED CHROMENOISOQUINOLINES SYNTHESIS AND METHODS FOR USE - Optionally substituted chromenoisoquinolines and analogs and derivatives thereof are described herein. In addition, syntheses of these compounds are described herein. In addition, uses of these compounds as dopamine receptor binding compounds are described herein. | 2009-01-29 |
20090030026 | Sustained release formulations of nalbuphine - Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided. | 2009-01-29 |
20090030027 | Androgen Receptor Modulator Compounds and Methods - Provided herein are compounds that bind to androgen receptors and/or modulate activity of androgen receptors, and to methods for making and using such compounds. Also provided are compositions including such compounds and methods for making and using such compositions. | 2009-01-29 |
20090030028 | Tetrahydroquinolines - Disclosed are compounds of formula (I), wherein W, R, R | 2009-01-29 |
20090030029 | Novel benzonaphthyridines - The compounds of formula I | 2009-01-29 |
20090030030 | ARYLALKENYL AND ARYLALKYNYL SUBSTITUTED IMIDAZOQUINOLINES - Arylalkenyl and aryalkynyl substituted imidazoquinoline compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed. | 2009-01-29 |
20090030031 | Method of Preferentially Inducing the Biosynthesis of Interferon - A method of preferentially inducing IFN-α biosynthesis in an animal comprising administering certain imidazo[4,5-c] ring compounds with a hydroxymethyl or hydroxyethyl substituent at the 2-position or pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of using these compounds a immunomodulators for treatment of diseases including viral and neoplastic diseases comprising preferentially inducing IFN-α biosynthesis in an animal are disclosed. | 2009-01-29 |
20090030032 | Bicyclic Compound, Production and Use Thereof - The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula: | 2009-01-29 |
20090030033 | Novel Compounds 894 - The invention relates to 2-aza-bicyclo[2.2.2]octane compounds and uses thereof. Particularly the invention relates to such compounds and their uses as pharmaceuticals in treating pyshoses such as schizophrenia and other diseases, disorders, or conditions. | 2009-01-29 |
20090030034 | USE OF FGF INHIBITING SUBSTITUTED 1,2,3 INDOLIZINE DERIVATIVES IN THE PREPARATION OF MEDICAMENTS WHICH CAN BE USED TO TREAT DISEASES LINKED TO PATHOLOGICAL CHOROIDAL ANGIOGENESIS - The present invention thus relates to the use of 1,2,3-substituted indolizine derivatives in the preparation of medicaments of use in the treatment of diseases related to pathological choroidal angiogenesis, which derivatives correspond to the following general formula (I): | 2009-01-29 |
20090030035 | 3-Aryloxy-8-aza-bicyclo[3.2.1]]oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors - This invention relates to novel 8-aza-bicyclo[3.2.1]oct-6-ene derivatives useful as monoamine neurotransmitter re-uptake inhibitors. | 2009-01-29 |
20090030036 | Nuclear receptor binding agents - The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity. | 2009-01-29 |
20090030037 | Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy - The invention relates to materials and methods for therapy to inhibit the production of leukotrienes, and therapeutic and prophylactic applications thereof. | 2009-01-29 |
20090030038 | Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor - The present invention relates to new compounds of formula I. (I) wherein R | 2009-01-29 |
20090030039 | Piperidine Derivatives as Cxcr3 Receptor Antagonists - The present invention relates to a compound of formula (I) | 2009-01-29 |
20090030040 | Substituted Heterocyclic Ethers and Their Use in CNS Disorders - The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders. | 2009-01-29 |
20090030041 | N-substituted N-(4-piperidinyl) Amide Derivative - An N-substituted N-(4-piperininyl)amide derivative represented by the following formula (I): (wherein R | 2009-01-29 |
20090030042 | Amide Addition Reaction - A method of making a compound of formula II | 2009-01-29 |
20090030043 | Potassium Channel Inhibitors - The present invention relates to tetraaryl methyl amine compounds and derivatives thereof having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like. | 2009-01-29 |
20090030044 | Crystal of Salt of Benzimidazole Compound - A crystal of a salt of 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole which is useful as a medicine, and use of the crystal. | 2009-01-29 |
20090030045 | FACTOR XA INHIBITORS - The present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to intermediates used in making such compounds, pharmaceutical compositions containing such a compound, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample. | 2009-01-29 |
20090030046 | NOVEL GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME - Compounds are provided which are activators of the enzyme glucokinase and thus are useful in treating diabetes and related diseases, which compounds have the structure | 2009-01-29 |
20090030047 | PERITONEUM PROTECTING AGENT - It is an objective of the present invention to provide a novel peritoneal membrane protecting agent which can effectively suppress deterioration of peritoneal functions in long-term peritoneal dialysis (PD) patients and the like. The present invention provides a peritoneal membrane protecting agent comprising a pyridoxine or a salt thereof, as an active ingredient. | 2009-01-29 |
20090030048 | Novel pharmaceutical compounds - The instant invention provides compounds of Formula Ia which are leukotriene biosynthesis inhibitors. | 2009-01-29 |
20090030049 | MEDICAMENT FOR GENITAL HERPES - [PROBLEMS] To provide a medicament useful for the treatment of genital herpes after the development of lesions. | 2009-01-29 |
20090030050 | Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use - Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 2009-01-29 |
20090030051 | Inhibitors of IMPDH enzyme - The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds. | 2009-01-29 |
20090030052 | PHARMACEUTICAL TABLET COMPOSITIONS CONTAINING IRBESARTAN - A pharmaceutical tablet composition comprising irbesartan and lactose, said composition being essentially free of surfactant. | 2009-01-29 |
20090030053 | FUNGICIDAL COMPOSITIONS - The invention relates to a composition capable of controlling phytopathogenic fungi on a plant or propagation material thereof said composition comprising as active ingredients a mixture of: (A) Difenoconazole or a salt or metal complex thereof; and (B) Chlorothalonil, wherein said Difenoconazole or the salt or metal complex thereof and said Chlorothalonil are present in said composition in amounts which produce a synergistic effect. The composition of the invention is also suitable for the protection of industrial materials. | 2009-01-29 |
20090030054 | CYTOPLASMIC ANTIGENS FOR DETECTION OF CANDIDA - The present invention relates to a method and a means of diagnosing | 2009-01-29 |
20090030055 | PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds - The present invention relates to compositions and methods to modulate α-secretase and/or to improve cognitive ability. The invention further relates the improved/enhanced cognitive ability in diseased individuals, particularly Alzheimer's Disease patients, and treatment thereof through increased sAPP production. Macrocyclic lactones (i.e. bryostatin class and neristatin class) are compounds preferred for use with the present composition. The present invention also provides methods for increasing the generation of non-amyloidogenic soluble APP comprising the activation of protein kinase C (PKC) by administering an effective amount of PKC activator(s). | 2009-01-29 |
20090030056 | NOVEL SODIUM CHANNEL BLOCKERS - The present invention is directed to novel phenyloin derivative compounds and the use of such compounds as sodium channel blockers. Such compositions have utility as anti-cancer agents and can be used to limit or prevent PCa growth and/or metastasis. | 2009-01-29 |
20090030057 | Pharmaceutical composition of telmisartan - The present invention provides a pharmaceutical composition of telmisartan comprising a) a telmisartan compound, b) a surfactant, c) a basic agent, and d) at least one diluent wherein the composition comprises less than 25% of water soluble diluents. The telmisartan compound is preferably present from about 12.5% to about 15.5%. At least one water insoluble diluent is preferred for use in the pharmaceutical composition in an amount from about 40% to about 70% of the total weight of the pharmaceutical composition. A preferred water insoluble diluent is microcrystalline cellulose. Also described are a pharmaceutical composition comprising telmisartan having a powder X-ray diffraction pattern, methods of preparing such pharmaceutical composition, and a crystalline form of Telmisartan. | 2009-01-29 |
20090030058 | TOSYLATE SALT OF 6- (4-BR0M0-2-CHL0R0PHENYLAMIN0) -7-FLUORO-N- (2-HYDROXYETHOXY) -3-METHYL-3H-BENZIMI DAZOLE- 5 - CARBOXAMIDE , MEK INHIBITOR USEFUL IN THE TREATMENT OF CANCER - The present invention relates to a tosylate salt of Compound 1 and polymorphs thereof, in particular crystalline and amorphous forms of Compound 1 tosylate salt, and methods of preparation thereof. Pharmaceutical compositions containing these salts as active ingredient, their use in the manufacture of medicaments for use in the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body, and their use in methods for the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body are also described. | 2009-01-29 |
20090030059 | PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE - Provided is a pharmaceutical composition for external use, including: (i) luliconazole represented by the following structural formula (1) and/or a salt thereof; and (ii) α-hydroxycarboxylic acid and/or a salt thereof. | 2009-01-29 |
20090030060 | INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS - The present invention provides a buffered non-flowing composition suitable for the treatment of bacterial vaginosis. The composition includes metronidazole in a concentration of about 0.50% (w/w) to about 1.50% (w/w). The metronidazole is present together with a buffer system in a physiologically tolerable medium. The buffer system provides an acidic buffered pH value for the composition in the range of about 5.0 to about 6.0. The present invention also provides for a method for inhibiting a microorganism. The method includes contacting a microorganism with an effective amount of the composition of the present invention, for a period of time effective to inhibit the microorganism. The present invention also provides for a method for treating bacterial vaginosis in a human patient. The method includes intravaginal administration to a patient in need of such treatment an effective amount of the composition the present invention. The composition is introduced into the vagina at least once a day for a time period of at least one day. | 2009-01-29 |
20090030061 | Benzoisoindole Derivatives And Their Use As EP4 Receptor Ligands - A compound of formula (I) or a pharmaceutically acceptable derivative thereof, | 2009-01-29 |
20090030062 | AZABICYCLO [3.1.0] HEXYLPHENYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (IA) or a salt thereof: | 2009-01-29 |
20090030063 | Combined pharmaceutical preparation for treatment of type 2 diabetes - For controlling the condition of type 2 diabetes, a pharmaceutical including a combination of mitiglinide, a pharmacologically acceptable salt thereof or a hydrate thereof and an α-glucosidase inhibitor such as voglibose or acarbose, and a therapeutic method using the pharmaceutical are provided. The pharmaceutical according to the present invention has an extremely strong effect of decreasing a morning fasting blood glucose level, a postprandial blood glucose level and HbA | 2009-01-29 |
20090030064 | Sugar-coated preparation - A preparation wherein an active ingredient unstable to oxygen is stabilized by coating a portion containing the active ingredient unstable to oxygen with a sugar-coated layer containing (1) sugar alcohol as a sugar-coating base material and (2) a binder is provided. | 2009-01-29 |
20090030065 | Use of Pde1c and Inhibitors Thereof - The present invention relates to the use of PDE1C as a novel target for the identification of compounds, which can be used for the treatment of pulmonary hypertension, fibrotic lung diseases or other fibrotic diseases outside the lung. The present invention further relates to the use of PDE1C inhibitors in the manufacture of pharmaceutical compositions for use in the therapy of those diseases. | 2009-01-29 |
20090030066 | SMALL MOLECULES FOR THE PROTECTION OF PANCREATIC CELLS - Embodiments of the present invention include the in vivo and in vitro use of a family of anticancer heterocyclic compounds containing a quaternary ammonium group as exemplified by the thioxanthone and thioxanthene compounds [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride, or CCompound1, N,N,-diethyl-N-methyl-2-[9-oxo-9H-thioxanthen-2-yl)methoxy]ethanaminium iodide, or CCompound3, and N,N,N-trimethyl-3-(9H-thioxanthen-9-ylidene)-propane-1-aminium iodide, or CCompound19 to maintain and increase viability of normal endocrine and exocrine pancreatic cells under pathological conditions, such as type 1 and type 2 diabetes, pancreatitis, pancreatic cancer, or during and after islet transplant, or in preparation for transplant of isolated islet cells via (i) direct contact with these cells, and/or via (ii) enhancing survival and proliferation of endogenous or transplanted adult stem cells, and/or via (iii) reducing viability of pancreatic cancer cells. | 2009-01-29 |
20090030067 | Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane - The present invention describes a method of prevention and/or treatment of a cancer or a tumor, and in particular a combination therapy, methods, compositions and pharmaceutical packages comprising a taxane and certain platinum-based chemotherapeutic agents. | 2009-01-29 |
20090030068 | Antitumour Compounds - The invention relates to novel antitumor compounds of general formula | 2009-01-29 |
20090030069 | INSECT REPELLENT WITH SUN PROTECTION FACTOR - An insect repellent composition that includes a blend of either all natural oils or synthetic ingredients, a sunscreen vitamin F, volatile silicones to extend the effective repellent life of the spray and a film forming polymer to resist water wash off. The natural oils and extracts can include citronella and orange and the synthetics can include D-limonene and phtalic acid. | 2009-01-29 |
20090030070 | EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE - To increase a tissue regeneration ability of a living body such as a collagens production ability of fibroblast in the dermis in a skin defect area typified by a large wrinkle or wound, a flavanone derivative such as farrerol is used as an active ingredient of an external preparation for skin. Further, to efficiently screen a substance having an excellent effect on promoting wound healing, the remodeling action of collagen fiber bundle is tested by using skin wound model. | 2009-01-29 |
20090030071 | Treatment of Cardiovascular Disease in Mexican Americans Using Nebivolol - Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such as, but not limited to, hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention relates to methods for treating and/or preventing cardiovascular disorders in persons of Hispanic descent, particularly Mexican Americans, using compositions comprising nebivolol. | 2009-01-29 |
20090030073 | PLANT-DERIVED THERAPEUTIC AGENT FOR MALIGNANT - A therapeutic agent for a malignant tumor containing a compound represented by the following formula (1) or (2): | 2009-01-29 |
20090030074 | SYNTHESIS, POLYMORPHS, AND PHARMACEUTICAL FORMULATION OF FAAH INHIBITORS - Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. The alkylcarbamic acid aryl ester of Formula (I), KDS-4103, is a FAAH inhibitor. Described herein is a process for the preparation of the compound of Formula (I), characterization of polymorphs of the FAAH inhibitor, and their uses therof. | 2009-01-29 |
20090030075 | Remedy for and Method of Treating Ischemic Cerebral Stroke - A drug for alleviating bleeding tendency caused by a thrombus removing means comprising, as an active ingredient, a compound represented by formula (I): | 2009-01-29 |
20090030076 | PROSTAGLANDIN DERIVATIVES - Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension. | 2009-01-29 |
20090030077 | Novel Fenofibrate Formulations and Related Methods of Treatment - The invention provides novel omega-3 oil liquid formulations of fenofibrate. These formulations can be substantially free of any food effect, effective in small volumes, and readily bioavailable. Notably, because the formulations of the invention contain an omega-3 oil as the major ingredient, they not only provide anithypercholesterolemic and antihypertriglyceridemic effects due to the fenofibrate active ingredient, they also provide recommended daily dosages of omega-3 oils (i.e., approximately 1 gram of omega-3 oil per day), or a portion thereof. | 2009-01-29 |
20090030078 | THERAPEUTIC AGENT FOR PAIN - The present invention relates to an agent for prevention, treatment or inhibition of symptom progression of a pain and/or for control of an analgesic comprising (2R)-2-propyloctanoic acid, a salt thereof or a prodrug thereof, in which an amount per dose is from 1 mg to 5000 mg (preferably from 10 mg to 5000 mg). By administering (2R)-2-propyloctanoic acid, a salt thereof or a prodrug thereof in an amount per dose within the range as described above, a pain, in particular, a neurogenic pain associated with a disease such as cancer pain, postherpetic pain, diabetic pain, HIV-associated neurogenic pain, calculus-induced pain, neuralgia, orofacial pain or hyperalgesia can be remarkably relieved. Moreover, undesirable effects on the living body relating to the use of an analgesic can be relieved. | 2009-01-29 |
20090030079 | USES OF TRIENTINE AND PENICILLAMINE AS COUNTERMEASURES TO METAL CONTAMINATION - Methods are provided for the alleviation, prevention and treatment of negative effects of overexposure to metal contaminants. Subjects exposed to a metal contaminant can be treated using trientine and/or penicillamine or salts, esters, solvates thereof. In addition, communities can protect its members by securing sufficient quantities of such countermeasures. | 2009-01-29 |
20090030080 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states - This invention provides a class of therapeutic compounds and methods for the treatment of mammals with physiological disorders, such as for example a frequently occurring type of essential hypertension, which are critically associated with the decreased binding of magnesium to the plasma membranes of their cells. These methods consist of administering to a mammal in need of such treatment a compound selected from a series of disubstituted trans,trans 1,3-butadienes, 1,3-disubstituted perhydrobutadienes, 1,2-disubstituted trans ethylenes and 1,2 disubstituted ethanes and disubstituted propanes, each of which embodies, in common, the unique structural feature essential for the biological activity of these compounds. This invention also provides for pharmaceutical formulations that employ these novel compounds. | 2009-01-29 |
20090030081 | USE OF LR-90 AND LR-102 TO OVERCOME INSULIN RESISTANCE - The present invention provides methods for ameliorating, overcoming, or inhibiting insulin resistance in a subject, comprising administering to the subject an effective amount of a compound selected from the group consisting of LR-90 and LR-102, or a pharmaceutically acceptable salt or derivative thereof. Methods of treating type 2 diabetes and diabetic nephropathy, or preventing or slowing their development are also encompassed by the invention. | 2009-01-29 |
20090030082 | SYNTHETIC LIGANDS SELECTIVE FOR LXRbeta OVER LXRalpha, IDENTIFICATION AND METHODS OF USE THEREOF - LXR nuclear receptor agonists have been previously shown to increase cholesterol efflux, raise plasma HDL cholesterol, stimulate cholesterol excretion, and reduce atherosclerotic lesions. However, these agonists have also been associated with the unwanted side effect of hypertriglyeridemia. This hypertriglyeridemia appears to be mediated by the LXRα subtype rather than LXRβ, which suggests that LXRβ-selective agonists are attractive candidates for modulation of human lipid metabolism. The present application provides novel LXRβ-selective ligands that preferably modulate LXRβ over LXRα. These ligands may be used to treat a variety of diseases associated with LXR, such as for example lipid metabolism disorders, atherosclerosis, Alzheimer disease, and inflammation. | 2009-01-29 |
20090030083 | Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury - N-(2-aryl-propionyl)-sulfonamides of general formula (I): | 2009-01-29 |
20090030084 | Compositions and Methods of Use of Electron Transport System Inhibitors - The invention provides compounds of the formula: or a pharmaceutically acceptable salt thereof, where m, n, R | 2009-01-29 |
20090030085 | USE OF BIS-AMINES TO ENHANCE THE ANTIMICROBIAL ACTIVITY OF AQUEOUS COMPOSITIONS - The use of bis-amines to enhance the antimicrobial activity of pharmaceutical compositions is described. The bis-amines are particularly useful for enhancing the antimicrobial activity of aqueous ophthalmic compositions, such as artificial tears or ocular lubricants, and solutions for disinfecting contact lenses. | 2009-01-29 |
20090030086 | ANTIMICROBIAL AGENTS - A benzoquinone or hydroquinone for use in the topical treatment of a condition which is caused, exacerbated or transmitted by bacterial, in particular staphylococcal or propionibacterial, activity. The condition may be a skin or skin structure condition such as acne. The invention also provides the use of a benzo- or hydroquinone in the manufacture of a medicament for the treatment of such a condition. | 2009-01-29 |
20090030087 | Extracts derived from chenopodium plants and uses thereof - The present invention relates to pesticides. More particularly, the present invention relates to botanical pesticides. In particular, the present invention relates to compositions and methods for controlling plant-infesting pests with plant extracts and notably with compositions comprising oil extracts derived from | 2009-01-29 |
20090030088 | Therapeutic benefits of gossypol, 6-methoxy gossypol, and 6,6'-dimothxy gossypol - 6-methoxy gossypol and 6,6′-dimethoxy gossypol were isolated from cottonseeds. Bioactivities of these two gossypol derivatives and gossypol were investigated regarding their antioxidant activities, DNA damage prevention ability, anti-cancer, and anti-trypanosomal activities. Both methoxy compounds had nearly equivalent bioactivities, but gossypol showed greater bioactivities than either methoxy derivative on free radical scavenging activity, reducing power, and DNA damage prevention ability. Gossypol and its methoxy derivatives inhibited growth of three cancer cell lines, i.e., SiHa (cervical cancer), MCF-7 (breast cancer) and Caco-2 (colon cancer) cells, in a dose dependent manner. These three compounds also significantly inhibited growth of trypanosome | 2009-01-29 |
20090030089 | Silicon Substituted Oxyapatite - The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca | 2009-01-29 |
20090030090 | Carbon nanotube reinforced polymer nanocomposites - The present invention is directed to carbon nanotube (CNT)/polymer composites, i.e., nanocomposites, wherein the CNTs in such nanocomposites are highly dispersed in a polymer matrix, and wherein the nanocomposites comprise a compatibilizing surfactant that interacts with both the CNTs and the polymer matrix. The present invention is also directed to methods of making these nanocomposites. In some such methods, the compatibilizing surfactant provides initial CNT dispersion and subsequent mixing with a polymer. The present invention is also directed to methods of using these nanocomposites in a variety of applications. | 2009-01-29 |
20090030091 | Brown Film Composition and Method for Preparing the Same - The present invention provides a film composition containing caramel (Caramel I, II, III or IV) as a brown colorant, particularly a film composition containing a water-soluble cellulose derivative as a base component and suitably used for a capsule base, the film composition ensuring high degree of transparency because of the suppression of caramel aggregation. The present invention also provides a method for preparing the brown film composition. The present invention is enforced by adjusting pH of an aqueous solution in forming a film composition, which is obtained by solidification of an aqueous solution containing a water-soluble cellulose derivative and caramel, to a predetermined range using a pH adjuster. | 2009-01-29 |
20090030092 | THICKENING AGENT - Thickening agents which containing a specific N-acylamino acid (component A) and a specific amideamine (component B) are capable of generating, when used in combination with a wide variety of oily bases including a hydrocarbon oil and silicone, a creamy thickening composition having a practical dissolution temperature and a smooth feeling in use when applied to the skin. | 2009-01-29 |
20090030093 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS - Process for the emulsion polymerization of one or more olefins by reacting a quinoid compound with a metal compound and a phosphine compound which is substituted by at least one polar radical and subsequently using the reaction product for the polymerization or copolymerization of olefins in water or in a solvent mixture which contains at least 50% by weight of water and at least one emulsifier. | 2009-01-29 |
20090030094 | Bottle excellent in recyclability and method for recycling the bottle - There are provided a bottle which has a laminate structure including a glycolic acid polymer layer showing good gas-barrier property in addition to a principal resin layer and is yet provided with excellent recyclability, and also an efficient method of recycling the bottle. More specifically, a bottle having a laminate structure including at least one layer of glycolic acid polymer in addition to a principal resin layer, is obtained. After breaking the bottle, the broken pieces are washed with alkaline water, water or acidic water to remove the glycolic acid polymer layer, thereby recovering the principal resin. | 2009-01-29 |
20090030095 | Polystyrene compositions and methods of making and using same - Disclosed is a method comprising contacting polystyrene with carbon black and expandable microspheres to form a composition, and expanding the microspheres to foam the composition. Also disclosed is a foamed composition comprising polystyrene, carbon black, and expandable microspheres. The inventive polystyrene compositions have improved mechanical properties. | 2009-01-29 |
20090030096 | METHOD OF PRODUCING EXPANDABLE POLYSTYRENE BEADS WHICH HAVE EXCELLENT HEAT INSULATION PROPERTIES - An expandable polystyrene bead production method, which is a two-step process, is disclosed. The method includes obtaining suspendable, homogenous micropellets from a mixed composition prepared by mixing graphite particles with a styrene-based resin and extruding the composition, and carrying out seed polymerization by suspending graphite-containing micropellets in water and adding a styrene-based monomer and an aromatic hydrocarbon having 6 to 10 carbon atoms, and impregnation by adding a blowing agent. The produced expandable polystyrene beads, which contain graphite particles, are considerably low in thermal conductivity. In addition, the expandable polystyrene beads exhibit a little change in the thermal conductivity over time due to the use of the graphite particles, so that the heat insulation property can be sustained for an extended period of time. | 2009-01-29 |
20090030097 | LINEAR POLYDIMETHYLSILOXANE-POLYOXYALKYLENE BLOCK COPOLYMERS LINKED VIA SIC GROUPS AND VIA CARBOXYLIC ESTER GROUPS, A PROCESS FOR PREPARING THEM AND THEIR USE - The invention provides linear polydimethylsiloxane-polyoxyalkylene block copolymers containing Si—C groups and carboxylic ester groups and having repeating (A | 2009-01-29 |
20090030098 | Propylene Polymers Having Broad Molecular Weight Distribution - Propylene homopolymers or copolymers containing up to 5.0 wt % of alpha-olefin units having from 2 to 8 carbon atoms other than propylene, characterized in that said propylene homopolymers or copolymers have Polydispersity Index value higher than 15, Melt Strength higher than 1.50 cN at 230° C. and Melt Flow Rate (ISO1133, 230° C./2.16 Kg) from 0.01 to 20 g/10 min. | 2009-01-29 |
20090030099 | FOAM COMPOSITION AND FOAM - An object of the present invention is to provide a foam having reduced hardness and density, and an improved resistance to compression set, as well as a foam composition for producing such a foam. This object is achieved by a foam composition described below. The foam composition of the present invention comprises a thermoplastic elastomer which has a side chain containing imino group and/or a nitrogen-containing heterocycle, and a carbonyl-containing group; and a blowing agent. | 2009-01-29 |
20090030100 | FINE PORE FORMATION AGENT FOR POROUS RESIN FILM AND COMPOSITION CONTAINING THE SAME FOR POROUS RESIN FILM - A fine pore formation agent for a porous resin film is provided which comprises inorganic particles satisfying (a) 0.1≦D50≦1.5 (μm) (D50: average particle diameter of particles in 50% cumulative total by weight from the larger particle side by micro-track FRA), (b) Da≦20 (μm) (Da: maximum particle diameter by micro-track FRA), (c) 3≦Sw≦60 (m | 2009-01-29 |
20090030101 | Dental adhesive compositions and methods - Two-part and one-part self-etching dental adhesives containing polymerizable acidic monomers. Methods include one-coat application without need for tooth etching. | 2009-01-29 |
20090030102 | METHOD OF FORMING A CROSSLINKED POLYMER GEL - The present invention relates to a method of forming a crosslinked polymer gel, to a polymer gel produced by such method and to uses of such polymer gel. | 2009-01-29 |
20090030103 | METHOD OF FABRICATING A THIN FILM TRANSISTOR SUBSTRATE AND A PHOTOSENSITIVE COMPOSITION USED IN THE THIN FILM TRANSISTOR SUBSTRATE - Disclosed is a method of producing a thin film transistor substrate having high light sensitivity, heat-resistance, impact resistance, and a photosensitive composition used by the same, the method including forming data wires on an insulating substrate, forming an organic insulating film on the data wires by applying a photosensitive composition comprising a terpolymer, where the terpolymer is derived from monomers of an unsaturated carboxylic acid, an unsaturated carboxylic acid anhydride, or a mixture thereof, an unsaturated epoxy group-containing compound, and an olefinic compound. | 2009-01-29 |
20090030104 | Active energy ray curable resin composition and sheet-like optical article - An active energy ray curable resin composition for a sheet-like optical article capable of providing a cured material having a dynamic elastic modulus at 25° C. of 950 MPa or less and a dynamic elastic modulus at 60° C. of 100 MPa or more and a sheet-like optical article prepared from the resin composition are disclosed. The sheet-like optical article (e.g., prism sheet) has good heat resistance and extremely small warpage. | 2009-01-29 |
20090030105 | METHOD FOR PRODUCING RUBBER-FILLER COMPOSITE - In a rubber-filler composite, the filler is uniformly finely dispersed, thereby improving low heat build-up, fatigue resistance and processability of a rubber composition. The rubber-filler composite is obtained by irradiating a filler slurry containing a filler such as carbon black or silica with high amplitude ultrasonic waves having amplitude of 80 μm or more to finely disperse the filler in the slurry, and mixing the dispersion-treated filler slurry with a rubber latex such as a natural rubber latex while conducting irradiation with high amplitude ultrasonic waves having amplitude of 80 μm or more, followed by coagulating and drying. | 2009-01-29 |
20090030106 | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same - The present invention is directed to reaction products prepared from at least one Michael addition donor material including two or more active methylene hydrogens; and at least one material capable of reacting with a Michael addition donor, the material having one Michael addition acceptor and at least one functional group selected from the group consisting of hydroxy, hydroxyalkyl, vinyl ether, amino, aminoalkyl, carboxy, carboxyalkyl, cyano, and cyanoalkyl groups; or reaction products prepared from (a) at least one Michael addition donor material comprising at least one Michael Addition donor group selected from the group consisting of cyano functional groups and phosphono functional groups; and (b) at least one material capable of reacting with the at least one Michael addition donor group, the material having at least one Michael addition acceptor, wherein the above reaction products are capable of forming free radicals upon exposure to actinic radiation; as well as compositions, and processes for making and using the same. | 2009-01-29 |
20090030107 | ENERGY RAY-CURABLE RESIN COMPOSITION AND ADHESIVE USING SAME - To provide an energy ray-curable resin composition which exhibits equally high adhesive strength to various objects to be bonded, such as glasses, metals and plastics and which has good heat resistance and moisture resistance and is excellent also in rigidity, particularly an energy ray-curable resin composition having a low cure shrinkage and little adhesion strain. | 2009-01-29 |
20090030108 | GEL COMPOSITION AND METHOD FOR PRODUCING SAME - A gel composition is provided, which in addition to being able to expect that various properties attributable to polyrotaxane will be retained, easily ensures stability, has superior shock absorbability and facilitates control of refractive index. The present invention provides a gel composition comprising a material having a network structure containing a polyrotaxane and a non-aqueous solvent, applications of the gel composition, and a process for preparing the gel composition. | 2009-01-29 |
20090030109 | Dental composite restorative material - The present invention includes a dental restorative material for use in for example, class 1 & 2 posterior cavity restorations. The inventive material includes a modified BisGma resin. The invention also includes a method of restoring a damaged tooth that includes the application of bonding agent, applying energy such as by warming the material so that it can be extruded, and placing the material into the tooth cavity. | 2009-01-29 |
20090030110 | Dental cement composition containing composite particles with grafted polyacidic polymer chains - A dental cement composition comprising
| 2009-01-29 |
20090030111 | Architectural Coating Compositions Containing Silicone Resins - An architectural coating composition is disclosed containing a silicone resin, an acrylic resin, a carrier, a pigment, a surfactant, and an optional additive. The silicone resin is a DT silicone resin, an MQ silicone resin, or an MTQ silicone resin. The carrier is water, a water compatible carrier, or a mixture of water and a water compatible carrier. The surfactant is an anionic surfactant, a nonionic surfactant, or a mixture of anionic surfactants and nonionic surfactants. | 2009-01-29 |
20090030112 | BIODEGRADABLE POLYMERIC COMPOSITION AND METHOD FOR PRODUCING A BIODEGRADABLE POLYMERIC COMPOSITION - Biodegradable polymeric composition and method for producing a biodegradable polymeric composition, comprising poly(hydroxybutyrate) or copolymers thereof, a plasticizer obtained from a renewable source, a nucleant additive, a flow aid additive, and a thermal stabilizer additive. The process of obtention comprises the steps of mixing to a load of PHB or PHBV in powder, from about 2% to 30% of a plasticizer based on vegetable oils of natural origin and fatty acids of animal and vegetable origin, distilled and hydrogenated; mixing to the biopolymer already containing the plasticizer a thermal stabilizer additive, a nucleant additive; and a flow aid additive; and extruding the composition obtained in the previous step to promote, in the melt state, the incorporation of the additives in the matrix of PHB or PHBV and its subsequent granulation. | 2009-01-29 |
20090030113 | UNIVERSAL PIGMENT PREPARATIONS - The invention relates to new universal pigment preparations having very good thermal stability and weathering stability as virtually foam-free aqueous, solventborne, and solvent-free pigment preparations and to their use in aqueous, solventborne or solvent-free coating materials, such as paints, adhesives, inks, including printing inks, and for coloring plastics. | 2009-01-29 |
20090030114 | Fluoropolymer emulsions - A core-shell emulsion polymer comprising
| 2009-01-29 |
20090030115 | Colored oxygen scavenging polymers - The present invention relates to a melt blend of a base polymer, an oxidizable organic polymer, a transition metal salt catalyst and a colorant that does not completely deactivate the catalyzed oxidation. A preferred colorant, yields in an article made from the polymer melt blend a Catalyst Deactivation Factor (CDF) of less than about 0.25, preferably less than 0.15, more preferably less than 0.1, and most preferred less than 0.05. The present invention also comprises a colored monolayer article having the described CDF, such as a film, thermoformed tray, or blow molded container, that has active oxygen scavenging properties. The colorant, after melt blending a base polymer, an oxidizable organic polymer, a transition metal catalyst, does not increase the binding energy of the transition metal catalyst ion by more than 1 eV. | 2009-01-29 |
20090030116 | Method and Composition for Producing an Item - A composition for producing a building item comprises: finely subdivided inert materials, an alkali metal polysilicate, an oxidizing agent, formaldehyde; a method for producing a building item comprises: dispersing finely subdivided inert materials in a solution of an alkali metal polysilicate, so as to obtain a mixture; adding an oxidizing agent and formaldehyde to said mixture; pouring said mixture into a mould, so as to enable said mixture to expand in volume, solidify and produce said item; drying said item. | 2009-01-29 |
20090030117 | POROUS POLYMERIC PARTICLE COMPRISING POLYVINYL ALCOHOL AND HAVING INTERIOR TO SURFACE POROSITY-GRADIENT - Embolic particles, as well as their methods of use and manufacture, are described. | 2009-01-29 |
20090030118 | Charged Thermoplastic Resin Based Bituminous Mastic - The invention relates to charged bituminous mastics that are used in industrial applications, particularly in the manufacture of indoor or outdoor coatings used for sealing and/or damping vibrations and/or thermal insulation and/or soundproofing and/or fire protection (fire-proofing). The aim of the invention is to provide a mastic which is deformation-resistant when thermally charged and which is also static in ambient temperature conditions prevailing during laying and when ambient temperature is 40° C., which also holds well when cold, offering good dimensional stability. In order to achieve said aim, styrene-indene copolymer resin having a Tg of 40-150° C. and a penetrability at 50° C. of ≦10 is used as a structuring agent A of a bituminous mastic comprising bitumen B, a charge C and a polymer D. | 2009-01-29 |
20090030119 | Process for Preparing a Benzoxazinone - The invention relates to a method for preparing a benzoxazinone comprising reacting an isatoic anhydride with an acylating compound in the presence of an N-alkyl imidazole, to a method for preparing a photo-stabilised composition, comprising adding a benzoxazinone and to the use of a benzoxazinone as a light-absorber or as a stabiliser for a light-sensitive compound. | 2009-01-29 |